FUNDAMENTALS · Fundamentals · US Consumer Defensive

The Procter & Gamble (PG) Fundamentals 2026 — P/E 21.5x, Revenue Analysis | SniperIQ

The Procter & Gamble (PG) is a US-listed Consumer Defensive company in Household & Personal Products with a market capitalization of

49.6B, trading at
50.12 on the NYSE. This SniperIQ fundamentals page covers The Procter & Gamble's valuation (P/E 21.5x, P/B 6.7x), profitability (net margin 19.2%), revenue ($84.3B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap
49.6B
P/E (TTM)21.5x
Net Margin19.2%
Revenue (FY25)$84.3B

Full research coverage

Frequently Asked Questions

What is The Procter & Gamble's market cap?

The Procter & Gamble (PG) has a market capitalization of approximately

49.6B, trading at
50.12 on the NYSE. Market cap moves with the live share price.

What is The Procter & Gamble's P/E ratio?

The Procter & Gamble's trailing twelve-month P/E ratio is 21.5x, with a price-to-book (P/B) of 6.7x. Valuation multiples are best compared with Consumer Defensive sector peers rather than read in isolation.

How profitable is The Procter & Gamble?

The Procter & Gamble runs a net profit margin of 19.2%, a gross margin of 50.3%, and an operating margin of 23.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does The Procter & Gamble generate?

The Procter & Gamble reported revenue of $84.3B for fiscal year 2025, with net income of

6.0B and earnings per share (EPS) of 6.67. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does The Procter & Gamble pay a dividend?

The Procter & Gamble offers a trailing dividend yield of about 2.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is The Procter & Gamble financially healthy?

The Procter & Gamble carries a debt-to-equity ratio of 0.68x and a current ratio of 0.73x, with a market beta of 0.38. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is The Procter & Gamble a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For The Procter & Gamble (PG) the key facts are: market cap

49.6B, P/E 21.5x, revenue $84.3B, 52-week range 137.62-167.25. Weigh valuation, profitability, growth, and balance-sheet strength against Consumer Defensive peers and form your own view.

Track The Procter & Gamble's full fundamentals live

Get The Procter & Gamble's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.